MRGM Research aims to decipher the molecular mechanisms laying at the root of the physiopathology of rare diseases and make our findings worth for patients.
Dr Thomas Langer, Max Planck Institute for Biology of Aging, Köln, Germany is invited by Giovanni Bénard (MRGM) and Stéphane Duvezin-Caubet (IBGC).
